Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cytek Biosciences (CTKB) Work In Process (2020 - 2026)

Cytek Biosciences filings provide 6 years of Work In Process readings, the most recent being $16.5 million for Q4 2025.

  • On a quarterly basis, Work In Process rose 154.79% to $16.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was $16.5 million, a 154.79% increase, with the full-year FY2025 number at $16.5 million, up 154.79% from a year prior.
  • Work In Process hit $16.5 million in Q4 2025 for Cytek Biosciences, up from $6.7 million in the prior quarter.
  • In the past five years, Work In Process ranged from a high of $16.5 million in Q4 2025 to a low of $1.5 million in Q1 2022.
  • Median Work In Process over the past 5 years was $6.0 million (2024), compared with a mean of $6.1 million.
  • Biggest five-year swings in Work In Process: soared 201.39% in 2023 and later tumbled 48.56% in 2024.
  • Cytek Biosciences' Work In Process stood at $2.3 million in 2021, then soared by 113.19% to $4.9 million in 2022, then skyrocketed by 113.48% to $10.5 million in 2023, then crashed by 37.94% to $6.5 million in 2024, then skyrocketed by 154.79% to $16.5 million in 2025.
  • The last three reported values for Work In Process were $16.5 million (Q4 2025), $6.7 million (Q3 2025), and $7.7 million (Q2 2025) per Business Quant data.